Welcome to LookChem.com Sign In|Join Free

CAS

  • or

20870-78-4

Post Buying Request

20870-78-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

20870-78-4 Usage

Chemical Properties

White to brown crytalline powder

Uses

5-Bromooxindole is an important raw material and intermediate used in organic synthesis, pharmaceuticals, agrochemicals and dyestuff.

Check Digit Verification of cas no

The CAS Registry Mumber 20870-78-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,8,7 and 0 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 20870-78:
(7*2)+(6*0)+(5*8)+(4*7)+(3*0)+(2*7)+(1*8)=104
104 % 10 = 4
So 20870-78-4 is a valid CAS Registry Number.
InChI:InChI=1/C8H6BrNO/c9-6-1-2-7-5(3-6)4-8(11)10-7/h1-3H,4H2,(H,10,11)

20870-78-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H50573)  5-Bromooxindole, 98%   

  • 20870-78-4

  • 1g

  • 1168.0CNY

  • Detail
  • Alfa Aesar

  • (H50573)  5-Bromooxindole, 98%   

  • 20870-78-4

  • 5g

  • 5238.0CNY

  • Detail
  • Alfa Aesar

  • (H50573)  5-Bromooxindole, 98%   

  • 20870-78-4

  • 1g

  • 1168.0CNY

  • Detail
  • Alfa Aesar

  • (H50573)  5-Bromooxindole, 98%   

  • 20870-78-4

  • 5g

  • 5238.0CNY

  • Detail
  • Aldrich

  • (586552)  5-Bromo-2-oxindole  97%

  • 20870-78-4

  • 586552-1G

  • 1,285.83CNY

  • Detail
  • Alfa Aesar

  • (H50573)  5-Bromooxindole, 98%   

  • 20870-78-4

  • 1g

  • 1168.0CNY

  • Detail
  • Alfa Aesar

  • (H50573)  5-Bromooxindole, 98%   

  • 20870-78-4

  • 5g

  • 5238.0CNY

  • Detail
  • Alfa Aesar

  • (H50573)  5-Bromooxindole, 98%   

  • 20870-78-4

  • 1g

  • 1168.0CNY

  • Detail
  • Alfa Aesar

  • (H50573)  5-Bromooxindole, 98%   

  • 20870-78-4

  • 5g

  • 5238.0CNY

  • Detail

20870-78-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Bromo-2-oxindole

1.2 Other means of identification

Product number -
Other names 5-BROMO-2-OXYINDOLE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:20870-78-4 SDS

20870-78-4Relevant articles and documents

A practical large-scale preparation of 5′-bromospiro(cyclohexane-1, 3′-[3H]indol)-2′(1′H)-one

Wilk, Bogdan K.,Rubezhov, Arkadiy,Helom, Jean L.,Routel, Lisa R.,Potoski, John R.

, p. 283 - 285 (2005)

-

Synthesis and Reactivity of 3,3-Diazidooxindoles

Holzschneider, Kristina,Mohr, Fabian,Kirsch, Stefan F.

, p. 7066 - 7070 (2018)

The synthesis of previously unknown 3,3-diazidooxindoles as synthetically useful derivatives of isatins was accomplished through the direct oxidative diazidation of 2-oxindoles. The method yielded the diazido compounds from the starting oxindoles under mild and simple conditions with NaN3 and iodine, in good yields. The notable reactivity of this new class of compounds toward primary and secondary nucleophilic amines is also described, which gives access to either 4-imino-3,4-dihydroquinazolin-2(1H)-one derivatives or cyanophenylureas.

Regiospecific synthesis of mono-n-substituted indolopyrrolocarbazoles

Froehner, Wolfgang,Monse, Barbara,Braxmeier, Tobias M.,Casiraghi, Laura,Sahagun, Heidi,Seneci, Pierfausto

, p. 4573 - 4576 (2005)

(Chemical Equation Presented) Two complementary and efficient strategies have been developed for the regiospecific synthesis of unsymmetrical indolopyrrolocarbazoles (IPCs) mono-N-substituted with a pentacycle. A halogen in position 2 of the intermediate bisindolylmaleimides 3a-e allows a selective Mitsunobu coupling by exploiting the increased acidity of the 2-chloro-substituted indole nitrogen. It also promotes an easier cyclization of bisindolylmaleimides 4a-e and 7b-e to IPCs. Alkylation of the 2-unsubstituted indole-3-carboxamides 2a,b and further processing to the corresponding IPCs gives access to the opposite regioisomers.

A novel methodology for the efficient synthesis of 3-monohalooxindoles by acidolysis of 3-phosphate-substituted oxindoles with haloid acids

Liu, Li,Li, Yue,Huang, Tiao,Kong, Dulin,Wu, Mingshu

, p. 2321 - 2328 (2021/09/22)

A novel method for the synthesis of 3-monohalooxindoles by acidolysis of isatin-derived 3-phosphate-substituted oxindoles with haloid acids was developed. This synthetic strategy involved the preparation of 3-phosphate-substituted oxindole intermediates and SN1 reactions with haloid acids. This new procedure features mild reaction conditions, simple operation, good yield, readily available and inexpensive starting materials, and gram-scalability.

Synthesis and biological evaluation of 3-substituted 2-oxindole derivatives as new glycogen synthase kinase 3β inhibitors

Lozinskaya, Natalia A.,Babkov, Denis A.,Zaryanova, Ekaterina V.,Bezsonova, Elena N.,Efremov, Alexander M.,Tsymlyakov, Michael D.,Anikina, Lada V.,Zakharyascheva, Olga Yu.,Borisov, Alexander V.,Perfilova, Valentina N.,Tyurenkov, Ivan N.,Proskurnina, Marina V.,Spasov, Alexander A.

, p. 1804 - 1817 (2019/03/23)

Glycogen synthase kinase 3β (GSK-3β) is a widely investigated molecular target for numerous diseases including Alzheimer's disease, cancer, and diabetes mellitus. Inhibition of GSK-3β activity has become an attractive approach for treatment of diabetes and cancer. We report the discovery of novel GSK-3β inhibitors of 3-arylidene-2-oxindole scaffold with promising activity. The most potent compound 3a inhibits GSK-3β with IC50 4.19 nM. In a cell-based assay 3a shows no significant leucocyte toxicity at 10 μM and is moderately cytotoxic against A549 cells. Compound 3a demonstrated high antidiabetic efficacy in obese streptozotocin-treated rats improving glucose tolerance at a dose of 50 mg/kg body weight thus representing an interesting lead for further optimization.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 20870-78-4